Skip to content
DraconiticResearch
Search Sources API
184,584 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BYHematological oncology

Non‐Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis

  • Sohaib Irfan1
  • Harshit Khosla2
  • Saad Nasir3
  • Manmeet Kaur4
  • Tyler J. Varisco5
  • Onyebuchi Ononogbu6
  • Sharda Singh7
  • Muhammad Bilal Abid7
7 affiliations
  1. 1The Aga Khan University School of Medicine
  2. 2The University of Texas Houston McGovern School of Medicine
  3. 3MD Anderson Cancer Center
  4. 4Center for Learning Health System Sciences University of Minnesota
  5. 5University of Texas at Austin College of Pharmacy
  6. 6University of Houston College of Pharmacy
  7. 7Texas Tech University Health Sciences Center, School of Medicine
Read full textPDFCite

Related

  1. The perceptions of hematopoietic stem cell transplantation decision-making in patients with hematologic malignancies: a qualitative systematic review.
    QingYing Wu, DanQi Chen, Fei Yuan +4
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Progressive multifocal leukoencephalopathy, bispecific antibodies, and multiple myeloma: a case report and systematic review of the literature
    Marina Tzanni, Panagiotis Polyzoidis, Konstantinos Angelopoulos +9
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  3. BISPECIFIC ANTIBODIES IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF EFFICACY AND SAFETY
    Isadora Medeiros ALMEIDA, Carolina Marsiglia LUCINI, Maria Fernanda Gonçalves Meirelles FERNANDES +5
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  4. Risk Factors and Outcomes of Vancomycin-Resistant Enterococcus faecium Bloodstream Infection in Hematologic Malignancies and Stem Cell Transplant Recipients: A Case-Control Study
    Open forum infectious diseasesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Global Burden of Disease Study on the Changing Landscape of Hematologic Malignancies and the Growing Impact of Elevated Body Mass Index — Asia, 1990–2023
    Yuan Wang, Ning Xu, Jingjing Guo +6
    China CDC weeklyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{irfan2026nonrelapse,
  title = {{Non‐Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis}},
  author = {Sohaib Irfan and Harshit Khosla and Saad Nasir and Manmeet Kaur and Tyler J. Varisco and Onyebuchi Ononogbu and Sharda Singh and Muhammad Bilal Abid},
  journal = {Hematological oncology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13674378},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Non‐Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis
AU  - Sohaib Irfan
AU  - Harshit Khosla
AU  - Saad Nasir
AU  - Manmeet Kaur
AU  - Tyler J. Varisco
AU  - Onyebuchi Ononogbu
AU  - Sharda Singh
AU  - Muhammad Bilal Abid
PY  - 2026
DA  - 2026/10/16
JO  - Hematological oncology
UR  - https://europepmc.org/article/PMC/PMC13674378
SN  - 0278-0232
SN  - 1099-1069
ER  -